Results first posted

Results first posted SURPASS-CVOT: tirzepatide against dulaglutide on major cardiovascular events

Source: A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

Results first posted SECURE

Source: Secondary Prevention of Cardiovascular Disease in the Elderly Trial

Results first posted FLOW: semaglutide and kidney outcomes in type 2 diabetes with chronic kidney disease

Source: A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

Results first posted SELECT: semaglutide and cardiovascular outcomes in overweight or obesity

Source: Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

Results first posted TRILUMINATE Pivotal trial

Source: TRILUMINATE Pivotal Trial

Results first posted CLEAR Outcomes (bempedoic acid in statin-intolerant people)

Source: Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo

Results first posted Look AHEAD: intensive lifestyle intervention in type 2 diabetes

Source: Look AHEAD: Action for Health in Diabetes

Results first posted EMPA-KIDNEY: empagliflozin in a broad range of chronic kidney disease

Source: EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

Results first posted DELIVER

Source: Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.

Results first posted EMPEROR-Preserved

Source: EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Results first posted PARTNER 3 trial

Source: PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

Results first posted Evolut Low Risk trial

Source: Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients

Results first posted FIDELIO-DKD: finerenone and kidney outcomes in type 2 diabetes

Source: Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Results first posted DAPA-CKD: dapagliflozin in chronic kidney disease

Source: A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease

Results first posted EMPEROR-Reduced

Source: EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

Results first posted DAPA-HF

Source: Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

Results first posted ISCHEMIA (initial invasive or conservative strategy for stable coronary disease)

Source: International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

Results first posted COAPT trial

Source: Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS

Results first posted Apple Heart Study Registry does not say if reached

Source: Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias

Results first posted DECLARE-TIMI 58: dapagliflozin and cardiovascular outcomes in type 2 diabetes

Source: Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Results first posted ODYSSEY OUTCOMES (alirocumab after acute coronary syndrome)

Source: ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Results first posted FOURIER (evolocumab in people with cardiovascular disease)

Source: Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk

Results first posted LEADER: liraglutide and cardiovascular events in type 2 diabetes

Source: Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

Results first posted IMPROVE-IT (ezetimibe added to simvastatin after acute coronary syndrome) Registry does not say if reached

Source: IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)

Results first posted PARADIGM-HF Registry does not say if reached

Source: This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure

Results first posted PROTECT AF Registry does not say if reached

Source: WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation (PROTECT AF)

Results first posted ARISTOTLE Registry does not say if reached

Source: Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation (ARISTOTLE)

Results first posted CHAMPION trial Registry does not say if reached

Source: CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients

Results first posted ROCKET AF Registry does not say if reached

Source: An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation (ROCKET AF)

Results first posted RE-LY Registry does not say if reached

Source: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate